Filters

See more specimen types...

Other countries

Results: 1 to 20 of 55 (representing 20 labs)

Tests names and labsConditionsGenes and analytesMethods

Limb-Girdle Muscular Dystrophy Sequencing Panel

Genetic Services Laboratory University of Chicago
United States
4630
  • C Sequence analysis of the entire coding region

Limb-Girdle Muscular Dystrophy Deletion/Duplication Panel

Genetic Services Laboratory University of Chicago
United States
3925
  • D Deletion/duplication analysis

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
7861205
  • C Sequence analysis of the entire coding region

MyoGene Panel (43 Genes)

Laboratory for Molecular Medicine Laboratory for Molecular Medicine (Partners HealthCare Personalized Medicine)
United States
10143
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Muscular Dystrophy (LGMD/EDMD) Panel (25 Genes)

Laboratory for Molecular Medicine Laboratory for Molecular Medicine (Partners HealthCare Personalized Medicine)
United States
6625
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Limb-girdle muscular dystrophy, autosomal recessive type 2L

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Neuromuscular Sequencing Panel

PreventionGenetics
United States
148124
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

ANO5. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

ANO5. Sequencing of the exons 5 and 20

Instituto de Medicina Genomica
Spain
11
  • E Sequence analysis of select exons

Limb-Girdle Muscular Dystrophy (LGMD) Sequencing Panel

PreventionGenetics
United States
3233
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Autosomal Recessive Limb-Girdle Muscular Dystrophy (LGMD) Sequencing Panel

PreventionGenetics
United States
2324
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Limb Girdle Muscular Dystrophy, Type 2L (LGMD2L) and Distal Miyoshi Myopathy (MMD3) via the ANO5 Gene

PreventionGenetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Limb-girdle muscular dystrophy panel

LifeLabs Genetics
Canada
2222
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Limb-Girdle Muscular Dystrophy Spotlight Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
8030
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Distal Myopathy Spotlight Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
5719
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Rhabdomyolysis Spotlight Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
7139
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Muscular Dystrophy Advanced Evaluation

Athena Diagnostics Inc
United States
5633
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Limb Girdle Muscular Dystrophy Advanced Evaluation

Athena Diagnostics Inc
United States
2623
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Distal Myopathy Advanced Sequencing Evaluation

Athena Diagnostics Inc
United States
3117
  • C Sequence analysis of the entire coding region

NGS Rhabdomyolysis and Metabolic Myopathies Panel

Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center
United States
4647
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 55

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center